Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells

References

• Abram CL, Courtneidge SA. Src family tyrosine kinases and growth factor signaling. Exp Cell Res 2000; 254: 1–13
   PubMed Web of Science ®Google Scholar
• Allen DL, Teitelbaum DH, Kurachi K. Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 2003; 284: C805–C815
   Web of Science ®Google Scholar
• Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 2005; 280: 41342–41351
   PubMed Web of Science ®Google Scholar
• Borgatti P, Martelli AM, Bellacosa A, Casto R, Massari L, Capitani S, Neri LM. Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 2000; 477: 27–32
   PubMed Web of Science ®Google Scholar
• Bottcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 2005; 26: 63–77
   PubMed Web of Science ®Google Scholar
• Bromann PA, Korkaya H, Webb CP, Miller J, Calvin TL, Courtneidge SA. Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J Biol Chem 2005; 280: 10253–10263
   PubMed Web of Science ®Google Scholar
• Canalis E, Centrella M, McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 1988; 81: 1572–1577
   PubMed Web of Science ®Google Scholar
• Caverzasio J, Palmer G, Suzuki A, Bonjour JP. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 2000; 15: 1697–1706
   PubMed Web of Science ®Google Scholar
• Celotti F, Colciago A, Negri-Cesi P, Pravettoni A, Zaninetti R, Sacchi MC. Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: Role of platelet-derived growth factor and transforming growth factor-beta. Wound Repair Regen 2006; 14: 195–202
   PubMed Web of Science ®Google Scholar
• Chaudhary LR, Avioli LV. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: Differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 1997; 238: 134–139
   PubMed Web of Science ®Google Scholar
• Chaudhary LR, Avioli LV. Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J Cell Biochem 2000; 76: 354–359
   PubMed Web of Science ®Google Scholar
• Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 2001; 81: 304–311
   PubMed Web of Science ®Google Scholar
• Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 2005; 280: 4632–4638
   PubMed Web of Science ®Google Scholar
• Chiariello M, Marinissen MJ, Gutkind JS. Regulation of c-myc expression by PDGF through Rho GTPases. Nat Cell Biol 2001; 3: 580–586
   PubMed Web of Science ®Google Scholar
• Choudhury GG, Mahimainathan L, Das F, Venkatesan B, Ghosh-Choudhury N. c-Src couples PI3K kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Cell Signal 2006, in Press
   Web of Science ®Google Scholar
• Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999; 71: 479–500
   PubMed Web of Science ®Google Scholar
• Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 1998; 335(Pt 1)1–13
   PubMed Web of Science ®Google Scholar
• Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res 2000; 256: 34–41
   PubMed Web of Science ®Google Scholar
• Debiais F, Hott M, Graulet AM, Marie PJ. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 1998; 13: 645–654
   PubMed Web of Science ®Google Scholar
• Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, Mascarelli F, Marie PJ. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res 2004; 297: 235–246
   PubMed Web of Science ®Google Scholar
• DeMali KA, Godwin SL, Soltoff SP, Kazlauskas A. Multiple roles for Src in a PDGF-stimulated cell. Exp Cell Res 1999; 253: 271–279
   PubMed Web of Science ®Google Scholar
• Du HJ, Tang N, Liu BC, You BR, Shen FH, Ye M, Gao A, Huang CS. Benzo[a]pyrene-induced cell cycle progression is through ERKs/cyclin D1 pathway and requires the activation of JNKs and p38 mapk in human diploid lung fibroblasts. Mol Cell Biochem 2006; 287: 79–89
   PubMed Web of Science ®Google Scholar
• Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16: 139–149
   PubMed Web of Science ®Google Scholar
• Franke TF, Kaplan DR, Cantley LC. PI3K: Downstream AKTion blocks apoptosis. Cell 1997; 88: 435–437
   PubMed Web of Science ®Google Scholar
• Globus RK, Patterson-Buckendahl P, Gospodarowicz D. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 1988; 123: 98–105
   PubMed Web of Science ®Google Scholar
• Godwin SL, Soltoff SP. Extracellular calcium and platelet-derived growth factor promote receptor-mediated chemotaxis in osteoblasts through different signaling pathways. J Biol Chem 1997; 272: 11307–11312
   PubMed Web of Science ®Google Scholar
• Gross D, Bernhardt G, Buschauer A. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: Selective tyrosine kinase inhibitors lack antiproliferative activity. J Cancer Res Clin Oncol 2006; 132: 589–599
   PubMed Web of Science ®Google Scholar
• Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000; 14: 2393–2409
   PubMed Web of Science ®Google Scholar
• Harris VK, Coticchia CM, Kagan BL, Ahmad S, Wellstein A, Riegel AT. Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways. J Biol Chem 2000; 275: 10802–10811
   PubMed Web of Science ®Google Scholar
• Hill PA, Tumber A, Meikle MC. Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 1997; 138: 3849–3858
   PubMed Web of Science ®Google Scholar
• Huang Z, Cheng SL, Slatopolsky E. Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 2001; 276: 21351–21358
   PubMed Web of Science ®Google Scholar
• Ichiki T, Tokunou T, Fukuyama K, Iino N, Masuda S, Takeshita A. 15-Deoxy-delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 323: 402–408
   PubMed Web of Science ®Google Scholar
• Iwabu A, Murakami T, Kusachi S, Nakamura K, Takemoto S, Komatsubara I, Sezaki S, Hayashi J, Ninomiya Y, Tsuji T. Concomitant expression of heparin-binding epidermal growth factor-like growth factor mRNA and basic fibroblast growth factor mRNA in myocardial infarction in rats. Basic Res Cardiol 2002; 97: 214–222
   PubMed Web of Science ®Google Scholar
• Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253: 210–229
   PubMed Web of Science ®Google Scholar
• Khan SN, Bostrom MP, Lane JM. Bone growth factors. Orthop Clin North Am 2000; 31: 375–388
   PubMed Web of Science ®Google Scholar
• Langdahl BL, Kassem M, Moller MK, Eriksen EF. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. Eur J Clin Invest 1998; 28: 176–183
   PubMed Web of Science ®Google Scholar
• Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996; 271: 20608–20616
   PubMed Web of Science ®Google Scholar
• Lee JT, Jr, McCubrey JA. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486–507
   PubMed Web of Science ®Google Scholar
• Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 2001; 276: 49343–49349
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002; 84-A: 1032–1044
   PubMed Web of Science ®Google Scholar
• Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 2000; 149: 1297–1308
   PubMed Web of Science ®Google Scholar
• Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 1993; 9: 73–80
   PubMed Web of Science ®Google Scholar
• Mehrotra M, Krane SM, Walters K, Pilbeam C. Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 2004; 93: 741–752
   PubMed Web of Science ®Google Scholar
• Mitlak BH, Finkelman RD, Hill EL, Li J, Martin B, Smith T, D'Andrea M, Antoniades HN, Lynch SE. The effect of systemically administered PDGF-BB on the rodent skeleton. J Bone Miner Res 1996; 11: 238–247
   PubMed Web of Science ®Google Scholar
• Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995; 136: 1276–1284
   PubMed Web of Science ®Google Scholar
• Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, Urakawa K, Ogata E, Matsumoto T. Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 1992; 7: 1149–1155
   PubMed Web of Science ®Google Scholar
• Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 2005; 16: 205–213
   PubMed Web of Science ®Google Scholar
• Parsons JT, Parsons SJ. Src family protein tyrosine kinases: Cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 1997; 9: 187–192
   PubMedGoogle Scholar
• Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 2001; 22: 153–183
   PubMed Web of Science ®Google Scholar
• Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti P. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 2002; 16: 598–600
   PubMed Web of Science ®Google Scholar
• Plotkin LI, Bellido T. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: A gap junction-independent action of connexin43. Cell Commun Adhes 2001; 8: 377–382
   PubMed Web of Science ®Google Scholar
• Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 165–197
   PubMed Web of Science ®Google Scholar
• Rodan SB, Wesolowski G, Thomas KA, Yoon K, Rodan GA. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 1989; 20: 283–288
   PubMed Web of Science ®Google Scholar
• Ronnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer 2001; 91: 757–762
   PubMed Web of Science ®Google Scholar
• Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005; 434: 786–792
   PubMed Web of Science ®Google Scholar
• Shah BH, Farshori MP, Jambusaria A, Catt KJ. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 2003; 278: 19118–19126
   PubMed Web of Science ®Google Scholar
• Suzuki A, Shinoda J, Kanda S, Oiso Y, Kozawa O. Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. J Cell Biochem 1996; 63: 491–499
   PubMed Web of Science ®Google Scholar
• Thisse B, Thisse C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 2005; 287: 390–402
   PubMed Web of Science ®Google Scholar
• Tsukamoto T, Matsui T, Fukase M, Fujita T. Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun 1991; 175: 745–751
   PubMed Web of Science ®Google Scholar
• Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326–1331
   PubMed Web of Science ®Google Scholar
• Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Luscher TF. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: Role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 1998; 97: 181–187
   PubMed Web of Science ®Google Scholar
• Zhang L, Leeman E, Carnes DC, Graves DT. Human osteoblasts synthesize and respond to platelet-derived growth factor. Am J Physiol 1991; 261: C348–C354
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin Y, Bowles C, Wang F. Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) kinase through phosphorylation-dependent release of Cks1 from FGFR substrate 2. J Biol Chem 2004; 279: 55348–55354
   PubMedGoogle Scholar
• Zhuang S, Schnellmann RG. Suramin promotes proliferation and scattering of renal epithelial cells. J Pharmacol Exp Ther 2005; 314: 383–390
   PubMed Web of Science ®Google Scholar
• Zimmermann O, Zwaka TP, Marx N, Torzewski M, Bucher A, Guilliard P, Hannekum A, Hombach V, Torzewski J. Serum starvation and growth factor receptor expression in vascular smooth muscle cells. J Vasc Res 2006; 43: 157–165
   PubMed Web of Science ®Google Scholar